Assura Plc (LON:AGR) insider Jonathan Murphy purchased 70,175 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was purchased at an average price of GBX 57 ($0.77) per share, with a total value of £39,999.75 ($53,835.46).
Assura Plc (AGR) opened at GBX 59.60 ($0.80) on Friday. Assura Plc has a 52 week low of GBX 51.35 ($0.69) and a 52 week high of GBX 67.30 ($0.91).
The company also recently declared a dividend, which will be paid on Wednesday, January 24th. Investors of record on Thursday, December 14th will be paid a GBX 0.66 ($0.01) dividend. This represents a yield of 1.13%. This is an increase from Assura’s previous dividend of $0.60. The ex-dividend date of this dividend is Thursday, December 14th.
COPYRIGHT VIOLATION NOTICE: “Assura Plc (AGR) Insider Jonathan Murphy Acquires 70,175 Shares” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/12/08/assura-plc-agr-insider-jonathan-murphy-acquires-70175-shares.html.
Assura Company Profile
Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.
What are top analysts saying about Assura Plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Assura Plc and related companies.